32704-59-9

Basic information

• Product Name: ETHYL-5-AMINO-2-PHENYLIMIDAZOLE-4-CARBOXYLATE
• Synonyms: ETHYL-5-AMINO-2-PHENYLIMIDAZOLE-4-CARBOXYLATE
• CAS NO: 32704-59-9
• Molecular Formula: C₁₂H₁₃N₃O₂
• Molecular Weight: 231.25052
• Mol File: 32704-59-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ETHYL-5-AMINO-2-PHENYLIMIDAZOLE-4-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL-5-AMINO-2-PHENYLIMIDAZOLE-4-CARBOXYLATE(32704-59-9)
• EPA Substance Registry System: ETHYL-5-AMINO-2-PHENYLIMIDAZOLE-4-CARBOXYLATE(32704-59-9)

Safety Data

• Hazardous Substances Data: 32704-59-9(Hazardous Substances Data)

Upstream product

• 72875-44-6 benzyl benzimidothioate 
• 32683-02-6 ethyl-2-aminocyano acetate 
• 2227-79-4 benzenecarbothioamide 
• 56503-39-0 ethyl (2E)-cyano(hydroxyimino)ethanoate 

Downstream Products

• 872784-25-3 5-amino-3-methyl-2-phenyl-3H-imidazole-4-carboxylic acid ethyl ester 
• 1071590-77-6 5-(N'-methyl-ureido)-2-phenyl-1⁽³⁾H-imidazole-4-carboxylic acid ethyl ester 
• 2879-14-3 8-Phenylxanthine 
• 2850-37-5 1-methyl-8-phenylxanthine 
• 37126-46-8 ethyl 5-diazo-2-phenylimidazole-4-carboxylate 

Relevant articles and documents

4-SUBSTITUTED PYRIDIN-3-YL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE

The invention relates to compounds of formula (I) which are useful as kinase inhibitors, more specifically useful as PIM kinase inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same, either alone or in combination, to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.